Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Tiffany Van Slyke"'
Autor:
Minakshi Taparia, Nancy Zhu, Aniket Bankar, Marlene Hamilton, Joseph Brandwein, Jeffrey M. Patterson, Tiffany Van Slyke, Elena Liew, Lauren Bolster, Lalit Saini, Mohammad Karkhaneh, Cynthia Wu, Darren Hallett
Publikováno v:
American Journal of Hematology. 96
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0658db793df24545a099efa2e3c49195
https://doi.org/10.1002/ajh.26012
https://doi.org/10.1002/ajh.26012
Autor:
Joseph Brandwein, Rosy Dabas, Don Morris, Tiffany Van Slyke, Poonam Dharmani-Khan, Jan Storek, Monica Modi, Andrew Daly, Joanne Luider, Faisal Khan
Publikováno v:
Bone marrow transplantation. 54(4)
Rabbit anti-thymocyte globulin (ATG (Thymoglobulin)) kills T cells in vitro and probably also in vivo as it prevents graft-vs-host disease (GvHD) in patients. Recently we demonstrated that ATG at a clinically relevant concentration (10–50 mg/L) kil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c4e0ff57412e7b5e64a26306531437b
https://pubmed.ncbi.nlm.nih.gov/30108326
https://pubmed.ncbi.nlm.nih.gov/30108326
Autor:
Monica Modi, Andrew Daly, Joseph Brandwein, Tiffany Van Slyke, Jan Storek, Faisal Khan, Joanne Luider, Poonam D. Khan, Don Morris, Rosy Dabas
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:S347
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0032d8954c5e3bc9dfdc51433df94bf4
https://doi.org/10.1016/j.bbmt.2017.12.413
https://doi.org/10.1016/j.bbmt.2017.12.413
Autor:
Poonam Dharmani-Khan, Loree Larratt, Rosy Dabas, Caylib Durand, Don Morris, Rachelle Lee, Maria Theresa Servito, Monica Modi, Faisal Khan, Tiffany Van Slyke, Joseph Brandwein, Andrew Daly, Joanne Luider, Jan Storek
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 22(5)
In contrast to cyclosporine or methotrexate, rabbit antithymocyte globulin (ATG) used for graft-versus-host disease (GVHD) prophylaxis with myeloablative conditioning does not increase the risk of relapse after hematopoietic cell transplantation. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5240cf78f0fc5410c95dd89b2f599042
https://pubmed.ncbi.nlm.nih.gov/26779931
https://pubmed.ncbi.nlm.nih.gov/26779931
Autor:
Monica Modi, Don Morris, Poonam Dharmani, Rosy Dabas, Tiffany Van Slyke, Joanne Luider, Andrew Daly, Faisal Khan, Joseph Brandwein, Jan Storek
Publikováno v:
Blood. 128:4616-4616
Background: Although curative treatment for acute myeloid leukemia, the success of allogeneic hematopoietic cell transplantation (HCT) is limited due to leukemia relapse and graft-versus-host disease (GvHD). Rabbit anti-thymocyte globulin (ATG) used
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f793436cbd82a48e88bc90ae53d8a06f
https://doi.org/10.1182/blood.v128.22.4616.4616
https://doi.org/10.1182/blood.v128.22.4616.4616
Autor:
Jan Storek, Caylib Durand, Loree Larratt, Tiffany Van Slyke, Rachelle Lee, Joanne Luider, Faisal Khan, Monica Modi, Poonam D. Khan, Maria Theresa Servito, Joseph Brandwein, Andrew Daly, Rosy Dabas
Publikováno v:
Blood. 126:5481-5481
Background/Rationale: Success of allogeneic hematopoietic cell transplantation (HCT) is limited due to graft-versus-host disease (GvHD) and leukemia relapse. Contrary to small molecule immunosuppressive drugs like cyclosporine or methotrexate, rabbit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40647aa50c3c2e7a2f74e10fe83818ee
https://doi.org/10.1182/blood.v126.23.5481.5481
https://doi.org/10.1182/blood.v126.23.5481.5481
Autor:
Brandwein, Joseph M., Hallett, Darren, Karkhaneh, Mohammad, Zhu, Nancy, Liew, Elena, Bolster, Lauren, Hamilton, Marlene, Patterson, Jeffrey, Taparia, Minakshi, Wu, Cynthia, Van Slyke, Tiffany, Bankar, Aniket, Saini, Lalit
Publikováno v:
American Journal of Hematology; Jan2021, Vol. 96 Issue 1, pE17-E20, 4p
Publikováno v:
Indian Journal of Hematology & Blood Transfusion; Nov2016 Supplement, Vol. 32, p373-492, 120p